기분조절제로 인한 인지기능 부작용이 동반된 양극성 기분장애 환자의 임상적인 특징: 아시아의 정신작용약물 처방 경향 연구(REAP-BD Survey) 중 국내 자료 활용open accessClinical Characteristics of Bipolar Disorder Patients with Mood Stabilizer-Induced Cognitive Side Effects findings from the REAP-BD Survey in Korea
- Other Titles
- Clinical Characteristics of Bipolar Disorder Patients with Mood Stabilizer-Induced Cognitive Side Effects findings from the REAP-BD Survey in Korea
- Authors
- 신희현; 최진희; 소형석; 최하연; 박용천; Tan, Chay Hoon; Lin, Shih-ku; Shinfuku, Naotaka; 박선철; 김기원
- Issue Date
- Aug-2020
- Publisher
- 대한신경정신의학회
- Keywords
- Bipolar disorder; Mood stabilizer; Cognitive side effect; 양극성 장애; 기분조절제; 인지기능 부작용
- Citation
- JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, v.59, no.3, pp.277 - 284
- Indexed
- KCI
- Journal Title
- JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION
- Volume
- 59
- Number
- 3
- Start Page
- 277
- End Page
- 284
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/145267
- DOI
- 10.4306/jknpa.2020.59.3.277
- ISSN
- 1015-4817
- Abstract
- Objectives This study aimed to identify differences between bipolar disorder patients who experienced cognitive side effects and those who did not experience cognitive side effects due to prescription of mood stabilizers.
Methods This study analyzed 350 Korean adults who were diagnosed with bipolar disorder and prescribed mood-stabilizing drugs. The patients were divided into two groups—patients who experienced cognitive side effects and those who did not experience cognitive side effects.
We also compared the demographic and clinical characteristics between both groups.
Results The number of patients with an untreated illness longer than 1 year was higher in the group of patients who experienced cognitive side effects compared to the group of patients who did not experience cognitive side effects. Further, the number of patients with manic symptoms at onset was higher in the group of patients who experienced cognitive side effects compared to the group of patients who did not experience cognitive side effects. In addition, the proportion of patients in remission was higher in the group of patients who experienced cognitive side effects compared to the group of patients who experienced no cognitive side effects. However, there was no significant difference regarding the type of mood stabilizer used between the groups. On the other hand, more people experienced cognitive side effects as the valproic acid dosage increased.
Conclusion Our findings suggest that there are clinical and demographic differences between people who experienced cognitive side effects and those who did not experience cognitive side effects due to prescription of mood stabilizers.
- Files in This Item
-
- Appears in
Collections - 서울 의과대학 > 서울 정신건강의학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/145267)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.